TGTX Q4 2017 Earnings — TG Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TGTXTG Therapeutics, Inc.

$5B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$38,095+0.0% YoY

Gross Profit

$38,095100.0% margin

Operating Income

-$31M-81466.7% margin

Net Income

-$31M-81007.4% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

-0.0%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$97M

Total Liabilities

$97M

Stockholders' Equity

$67M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38,095	$38,095	+0.0%
Gross Profit	$38,095	-$79.0B	+100.0%
Operating Income	-$31M	-$24M	-29.2%
Net Income	-$31M	-$24M	-30.4%